Gilenya, the first oral MS treatment, approved in Europe

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya, the first oral MS treatment, approved in Europe

Postby MSUK » Mon Mar 21, 2011 8:16 am


The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (RRMS) despite treatment with beta interferon, or in patients with rapidly evolving severe RRMS.

"Today marks an important step forward in the way we manage this chronic, debilitating disease in Europe,” said Professor Hans-Peter Hartung, Professor and Chairman, Dept. of Neurology, Heinrich-Heine University, Germany. “Gilenya is the first approved therapy for MS that offers significant efficacy in a capsule, which for many patients will come as a welcome additional option.”... Read More - ... ageid/1309
User avatar
Family Elder
Posts: 2501
Joined: Wed Oct 14, 2009 2:00 pm


Return to Gilenya


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service